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Abstract
Aims: The purpose of this thesis was to synthesize the current literature on alpha amylase as an
emerging biomarker of microaspiration in mechanically ventilated patient.

Methods: The methodology included a review and synthesis of pertinent research articles from
1981-2018, written in English language. Criteria for inclusion in the review were all articles that
evaluated α- amylase in tracheal secretions or bronchoalveolar lavage fluid (BAL) as a
diagnostic tool for identifying microaspiration. The search yielded 11 studies that were reviewed.
Findings: The findings suggest that once aspiration occurs, the duration of α-amylase in the
lungs requires further exploration to assist in interpretation of positive values. After these values
are identified they need be used consistently used throughout practice of mechanically ventilated
patients. Inconsistencies in the defining parameters of α-amylase were used with the thirteen
studies.

Conclusion: Testing amylase levels can require financial stability, standardized training, and
timeliness of collecting the specimen. Alpha-amylase is a biomarker of microaspiration. Further
research should be conducted to evaluate the biomarker capabilities of α-amylase to assist in
early identification and/or prevention of microaspiration in mechanically ventilated patients.
Implications for nursing policy practice, education, and considerations for upcoming research of
α-amylase were reviewed with limitations to the study.
Key words: Mechanical ventilation, nursing, ventilator associated events, pneumonia, αamylase, aspiration biomarker, aspiration
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INTRODUCTION
Microaspiration is a potentially serious complication that can occur in intubated patients
who are in critical conditions. Microaspiration entails the seepage of subglottic secretions around
the endotracheal tube (ETT) (Blot, Poelaert, and Kollef, 2014; Nseir, Zerimech, Jaillette, Artru,
& Balduyck, 2011), VAP results in increased lengths of stay in the intensive care unit (ICU) and
hospital and requires a team of ICU staff to provide around the clock care to affected patients.
Rather than focus on VAP, current practice is to monitor for complications known as Ventilator
Associated Events (VAE). VAE occur from a decline in oxygenation after a patient has
previously stabilized, positive cultures of a respiratory infection, and diagnostic tests indicating
infection or inflammation of the lungs (Center for Disease Control and Prevention, 2018).
Critically ill patients are susceptible to aspirating on their own oral secretions while confined in
their hospital beds (VanBlarcom & McCoy, 2018). Microaspiration can cause damage and
contamination to the respiratory tract. This can leave patients with various secondary diseases:
decreased cardiac output, respiratory alkalosis, increased intracranial pressure (ICP), distended
abdomen, pneumothorax, and hospital- acquired infections, among other issues (Drašković &
Rakić, 2011). The secretions that seep past the ETT tube may be found within the lungs of
patients on mechanical ventilators.
Amylase is an enzyme that is found usually in saliva or pancreatic secretions. Amylase
converts starch into simple sugars inside the body (Medline, 2019). Patients are susceptible to
many infections and complications when they are on a ventilator. More research needs to be
conducted on the prevalence of α-amylase when found in the lungs compared to other locations
in the human body. As well as, what a safe amount of α-amylase to have in the body before it
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becomes a problem. Patients can aspirate both oral and/or gastric secretions. Aspiration of oral
contents may be identified by detecting levels of α-amylase on tracheal secretion. Patients with
α-amylase do not have protocols in place to identify the degree of severity in their lungs. αamylase has been associated with patients who have experienced microaspiration (Dewavrin et
al, 2014).
New research is suggesting α-amylase in tracheal secretions as a potential biomarker for
detection of microaspiration of secretions around a breathing tube into the lungs; however,
defined limits of its use have not been described. Few studies have acknowledged α- amylase as
an imperative biomarker for aspiration pneumonia patients (Rouzé, Jaillette, and Nseir, 2018).
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Purpose
The purpose of this thesis was to analyze the research that has been conducted on α-amylase in
tracheal secretions of intubated patients.
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METHOLODGY
A literature search was conducted, and findings are reported as a literature review.
Multiple databases were searched: MEDLINE, CINAHL, PsycInfo and Academic Search. Key
terms used were, “alpha-amylase or amylase* OR (MH "Amylases") AND (MH "Biological
Markers") OR marker* or "bio* marker" or biomarker*) AND (aspirat* or Suctioning or
bronch* or pulmonary or endotracheal or ventilat*. There were no restrictions on publication
dates. Inclusion criteria consisted of the English language. All articles with α- amylase as a
diagnostic tool for identifying microaspiration and indicators of α-amylase in bronchoalveolar
lavage fluid (BAL) were included.

From the original search with MEDLINE, CINAHL, PsycInfo, and Academic Search,
(n= 77) articles were identified. Articles excluded discussed various properties of α-amylase with
investigative research on preventing various medical conditions and their complexities that
follow asthma, organ failure, high-intensity stress, and motor vehicle accidents. Articles were
excluded due to not meeting the inclusion criteria (n = 68) of relating specifically to
mechanically ventilated patients. Articles specific to amylase and its clinical significance in
ventilated patients (n=9). Additional studies were found through review of article reference lists
(n=2). A total of eleven studies were included in this review. These eleven articles that discussed
α-amylase in ventilated patients were further investigated for their credibility in this literature
review.
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FINDINGS
A comprehensive review of literature findings was completed to discuss the role of αamylase as a biomarker for aspiration and complications of ventilation. Dewarvin et al, (2014)
compared α-amylase levels in 109 patients in an ICU in a retrospective analysis. Of the patients
that were included in the study there was 1055 tracheal aspirates. The value of a tracheal aspirate
of α-amylase in a patient was >1688 IU/L to be deemed positive (Dewarvin et al, 2014).
Weiss et al (2011), measured α-amylase in 296 BAL specimens from 280 patients that
classified with a minimum of one risk factor of aspiration. These risk factors were difficulty
swallowing, a decreased level of consciousness, cardiac infarction, a problem while being
intubated, and vomiting within sixty minutes of an ETT tube being placed. The values that were
used for this study were based off three categories of patients. One risk factor had 70 IU/L (22
IU/L-17 IU/L; one risk factor, 253 IU/L (58 IU/L-623 IU/L), patients with a positive BAL gram
stain (359 IU/L (154 IU/L-1453 IU/L) vs. 66 IU/L (26 IU/L-165 IU/L), p<0.001). Levels were
higher in patients with a positive culture for bacteria, normal flora, or yeast compared to a
negative culture, and patients with positive culture for bacteria, normal flora, or yeast 25.15
IU/L[94 IU/L-832 IU/L] vs.63 IU/L [22IU/L], p<0.001 (Weiss et al, 2011). Individuals who
were intubated for at least 72 hours were found to have α-amylase. Dewarvin et al and Weiss et
al, suggested that measuring α-amylase was an efficient diagnostic tool that would allow for
testing of critically ill patients.
Samanta et al (2018) conducted a prospective observational study of 151 patients who
were also intubated for at least 72 hours. α-amylase was evaluated in mini-BAL specimens and it
was explored for association with VAP. OF the 151 patients 64.9% tested patients presenting
with VAP. VAP patients had significantly higher median mini BAL α-amylase values than those

5

without VAP (287 IU/L vs. 94 IU/L, p<0.001). Patients that had none or up to 4 pre-intubation
risk factors were 65 IU/L, 200 IU/L, 867 IU/L, and 3453 IU/L (p < 0.001). Median amylase in
patients with 1 and 2 post intubation risk factors were 472 IU/L and 731 IU/L (p <0.001)
(Samanta et al, 2018).
One of the 11 articles included a population of children. Abu-Hasan et al, utilized 67
chronically ill children with respiratory illnesses that needed a bronchoscopy (Abu-Hasan et al,
2014). α-amylase was found to be significantly higher in bronchoalveolar lavage (BAL)of gram
stains in positive BAL cultures (1,632 vs. 84 IU/L; p=0.049), and in positive BAL oral flora
cultures (1,803 vs. 270 IU/L; p=0.004) (Abu-Hasan et al, 2014).
Bai et al, expanded on the findings of the research Weiss et al (2013) investigating the
effect of α-amylase an indicator of aspiration. The study included 280 mechanically ventilated
patients of these 296 BAL samples were accumulated (Bai et al, 2013). The predictors of high
amylase had a limit of 125 IU/L (Bai et al, 2013). Bronchial secretions were also analyzed in a
study with Bain, Clarke, Davies, Levin, and Lamber (1981). The patient population was 21
adults who acquired transtracheal aspiration chest infections. This exploratory/observational
study found that amylase activity was 50,000 IU/L.
In France there were 10 ICU’s that were incorporated into a study conducted by Jaillette,
et al. Pepsin and α-amylase were evaluated in 2739 tracheal aspirates from 303 patients in the
hospitals. Amylase levels that were > 1685 IU/mL in >30% of tracheal aspirated per patient
(Jaillete et al, 2017). A prospective study was initiated that comprised of 26 intubated patients
that were sedated for at least 48 hours and had a HiLo ETT (Filloux et al, 2019). These 26
patients were considered a high risk for microaspirating. The oral amylase group compared
between intubation groups of tracheal and subglottic study groups, oral had the highest numbers
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of amylase accumulation of (307,606 [200,725-461,300] IU/L). Tracheal amylase was decreased
in the control group of intubated patients where group where the median values IQR were as
follows (191 [10–917] vs 6661 [2774–19,358] IU/L, p <0.001). Subglottic amylase levels were
(130,750 [55,257-157,717] IU/L (Filloux et al, 2019).
There were 15 patients that were mechanically ventilated with Shiley tracheostomy on
low pressure and high-volume settings participated in a study on alpha-amylase activity in
tracheobronchial secretions (Nandapalan et al, 1995). The α-amylase ranges that were used were
(35-1125 IU/L; median 295 IU/L (Nandapalan et al, 1995). A retrospective analysis of 147
elderly patients associated with VAP were grouped into a study by Qu et Al (2018). Their
analysis revealed that patients with 3 or more risk factors for having a complication that required
intubation, having a Glasgow coma scale score of <8, without subglottic secretions, and had αamylase levels of >4,681.5 IU/L (Qu et al, 2018).
Sole et al (2014) conducted a descriptive study to review the existence of pepsin and
amylase in oral-tracheal secretions of mechanically ventilated adult patients. From a study not
yet published levels of aspiration of α-amylase were no aspiration (0 to 392 IU/L), low aspiration
(392 to 1,499 IU/L), moderate (1,500 to 4,999 IU/L), high (> 5,000 IU/L). These levels were
used to categorize patients for risk for complications from a different study (Sole, et al
unpublished data).
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DISCUSSION
Each of these articles utilized a different range of values to help quantify the amount of
α-amylase in patients’ secretions. Filloux et al, had used oral, subglottic, and tracheal secretions
of α-amylase to determine the difference in each section of the upper airway. Whereas,
Dewarvin, Weiss, Bain, and Abu-Hassan focused on the location of BAL secretions. A weakness
in Dewarvin’s study included their sample size of tracheal aspirates from patients and that their
cut-off range of 1688 IU/L could have falsely reinforced the results. The patients that were on
the ventilators in the hospital also did not have their markers for microaspiration consistently
trended during their hospital stay (2014). Sole et al, reiterates that microaspiration of oral and
gastric secretions occur often even though pepsin was more commonly detected in the 2014
study. Qu et al, found that α-amylase can be a prognostic tool for identifying VAP. The higher
the levels of tracheal aspirates the higher the likelihood of VAP occurring. Tracheal aspirate αamylase levels exceeded more than 4681.5 IU/L elderly patients.
An acceptable level of secretions containing α-amylase must be established to set
standardized parameters in practice (Gatell et al, 2012). Samanta et al, agrees that the lack of a
gold standard limits the diagnosis for aspiration. Small sample sizes of intubated patients need to
be expanded to further validate α-amylase analytic abilities. Once aspiration occurs, the duration
of α-amylase in the lungs requires further exploration to assist in the interpretation of positive
values. Researchers are still unaware of how long α-amylase occurs in the lungs which calls for
uncertainty of its destruction leading to VAP. An exact range for positive aspiration has yet to be
defined.
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IMPLICATIONS FOR NURSING
Education
Currently nursing education in some areas does not consist of information on α-amylase
and its biomarker capabilities. As evidence-based practice continues to be updated in the
research setting this information needs to be transferred from the bedside to the classroom.
Student nurses have a right to be informed and brought in on new data. Nurses swear an oath to
become a patient advocate. A part of being a patient advocate means knowing the best possible
form of treatment. Hospitals have nurse educators who are constantly providing informational
packets and assignments to nurses to have current EBP. However, there are no values being
taught in the hospitals for nurses to look for because more research must be done to find how
significant these values are.
Practice
Applying α-amylase in the nursing profession requires commitment of the nurses and the
hospitals to regulate the values of α-amylase. Once aspiration occurs, the duration of α-amylase
in the lungs requires exploration to assist in the interpretation of positive values. This means that
more work needs to be done to have an established cutoff level of α-amylase. An established
cutoff level will facilitate comparison of patient populations, interventions, and outcomes.
Research
Weiss et al, stated that more research needs to be conducted on α-amylase as a biomarker
for microaspiration (2013). At risk patients that have private health information such as a history
of HIV/AIDS or risk factors that are unknown are unable to be identified within the hospital
setting to prevent ventilator associated events (VAE) and VAP. Further funding would need to be
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provided for researchers to continue the development of α-amylase as a biomarker for
microaspiration.
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SUMMARY
More research is needed to associate α-amylase as a primary biomarker for assessing for
aspiration and look at risks for pulmonary complications, such as VAP. There is not enough
education in the field of nursing on this topic to create a standard competency. More information
on the universal diagnostic ranges of α-amylase need to be investigated further. Financial
stability, regulated training, and suitability of gathering samples are potential barriers to a
prospective life changing implementation. Though these barriers can seem vastly inaccessible for
individuals in healthcare research, the outcomes can outweigh these factors.
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APENDIX A

FIGURE Ⅰ: PRISMA FLOW CHART
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Articles were identified after an initial screening of the
following databases with key search terms. (CINAHL,
PsychINFO, Academic Search Premiere, MEDLINE)
(n = 77)

Articles were excluded
due to not meeting the
inclusion criteria
(n = 68)

Articles specific to amylase
and its clinical significance in
ventilated patients
(n=9)

These studies were reviewed, hand selected
for use, included the inclusion criteria, and
were specific to the current focus for the
study
(n = 11)
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APENDIX B

TABLE Ⅰ: TABLE OF EVIDENCE
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Study

Purpose

Sample
Size

Study Design

Methodology and Instruments

Findings and Conclusions

Comments/Limitations

Abu-Hasan M,
Elmallah M, Neal
D, Brookes, J.
Salivary amylase
level in a
bronchoalveolar
fluid as a marker of
chronic pulmonary
aspiration in
children. Pediat
Aller Imm Pul.
2014;27(3), 115119.

Explore the use
of salivary
amylase in
bronchoalveolar
lavage (BAL)
fluid as a
diagnostic tool
for chronic
pulmonary
aspiration
(CPA) in
children

64 children
with
chronic
respiratory
illness
requiring
bronchosco
py were
included.

A
retrospective
review of
BAL amylase
and medical
records.

Amylase in BAL fluid was
measured by a functional assay
using photometric techniques.
Analysis of variance, Student’s ttest, logistic regression analysis,
and correlation analysis was
utilized to assess statistical
significance.

When the high and low-risk
groups were combined, a
significant difference (p=.03)
(higher amylase levels of
1,722 vs. 307 IU/L) was
noted compared to the
remaining group.

Variability in amylase
levels existed among
groups, potentially due
to equipment
contamination with
upper airway secretions
and/or acute aspiration
during the
bronchoscopy.

Patient clinical and demographic
variables were analyzed using
multiple regression analysis to
determine any impact on BAL
amylase.

BAL amylase was
significantly higher in the
following groups: positive
BAL gram stains (1,857 vs.
479 IU/L; p=0.014), in
positive BAL cultures (1,632
vs. 84 IU/L; p=0.049), and in
positive BAL oral flora
cultures (1,803 vs. 270 IU/L;
p=0.004).

It is impractical to fully
generalize results of
children to adults due to
differing variables (i.e.,
young age and inevitable
aspiration).

Standardization of and
collection of urea levels
are suggested in the
BAL collection process
to reduce variability.

Bai C, Liu J, Song
Y. Amylase in
bronchoalveolar
lavage fluid: a new
marker of
pulmonary
aspiration. Critical
Care Med.
2013;41(3), 916917.

To discuss the
findings of
Weiss et al.
(2013)
exploring the
impact of αamylase as a
predictor of
aspiration.

280
mechanical
ly
ventilated
patients
from five
medical
centers
were
included.
Of these

This study
provided an
overview of
Weiss et al.
(2013) and
the
retrospective
study design
utilized.

The correlation between BAL
amylase concentration, BAL
microbial culture results, and preintubation aspiration risk factors
were assessed.

15

A strong association existed
between BAL amylase and
risk factors for aspiration.
With a BAL amylase
concentration cutoff of < 125
IU/L, the sensitivity was
70% for predicting bacterial
pneumonia (negative
predictive value of 85%).

No, a “gold standard”
exists for diagnosis of
bacterial pneumonia.
Due to the evolving
nature of BAL amylase,
several measurements
should be done rather
than one. BAL amylase
collection requires
training (requiring time
and financial resources).

Study

Purpose

Sample
Size

Study Design

Methodology and Instruments

Findings and Conclusions

patients,
296 BAL
samples
were
collected.
Bain B.C, Clarke
P.D, Davies A,
Levin G.E, Lamber
H.P. Aspiration in
seriously ill
patients: A study of
amylase in
bronchial
secretions. Journal
of Clinical
Pathology,
1981;34, 803-805.

To explore the
increased levels
of amylase
activity in the
bronchial
secretions in
patients in the
ICU.

21 patients
with
moderate to
severe
chest
infections
were
obtained by
transtrache
al
aspiration.

A standardization of
collection mechanisms
for BAL amylase
(collection volume and
location) is
recommended.
Exploratory/o
bservational
Quantitative

ES was collected either
immediately before or during the
TTA procedure in alert patients,
but pharyngeal suction specimens
were used in some of the seriously
ill patients. Specimens were stored
at + 4°C for a variable period of
up to three weeks before
estimation of the amylase
activities. Sera taken at the time of
the procedure were stored at 20°C for similar periods before
analysis. The specimens were
diluted and homogenized with
dithiothreitol.

In seriously ill patients the
mean TTA amylase activity
was 50 000 IU/L while in the
less ill patients it was 1565
IUL (p < 0 0005). The mean
ES amylase activity was 206
000 IU/L. The mean serum
amylase activity was 260
IU/L. Although TTA is a
valuable diagnostic method
in difficult pulmonary
infections, contamination by
oropharyngeal flora is not
uncommon and will cause
difficulties of interpretation.
The second findings serve as
a reminder of the frequency
and importance of aspiration
in seriously ill patients.

Dewavrin F,
Zerimech F, Boyer
A, et al. Accuracy

The purpose of
this study was
to determine the

1055
tracheal
aspirates,

Comments/Limitations

Retrospective
analysis of
prospectively

Pepsin was quantitatively
measured in all tracheal aspirates
during a 48-h period. All tracheal
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Mean α-amylase level, and
percent of tracheal aspirates
positive for α-amylase were

The reproducibility of
this method for
estimating amylase in
sputum and tracheal
aspirate is poor, partly
due to the lack of
homogeneity of the
samples, and partly to
the difficulty of pipetting
viscous material, with a
coefficient of variability
of 27% on nine paired
samples.
The seriously ill patients
(6/21) had all undergone
pharyngeal suction and
nasogastric intubation as
routine nursing
procedures in the ICU;
these procedures could
have yielded to the high
levels of amylase
activity found in TTA
samples. Compared to
the fifteen who were not
given the same
treatments.
The use of α-amylase as
a diagnostic tool for
microaspiration is

Study

Purpose

Sample
Size

Study Design

Methodology and Instruments

Findings and Conclusions

Comments/Limitations

of α-amylase in
diagnosing

accuracy of αamylase in
diagnosing
microaspiration
in critically ill
patients.

collected
from 109
patients.

collected
data.

aspirates were frozen and later
tested for α-amylase.

significantly higher in
patients with
microaspiration, and in
patients with abundant
microaspiration compared
with those with no
microaspiration; and similar
in patients with
microaspiration compared
with those with abundant
microaspiration.

moderate. It was found
to be less conclusive
when compared to
pepsin and often
inaccurate.

microaspiration in
intubated critically
ill patients. Plos
One. 2014;9(3),
e90851.

Microaspiration was defined as
the presence of at least one
positive tracheal aspirate for
pepsin (>200 ng/mL). Abundant
microaspiration was defined as the
presence of pepsin at a significant
level in >74% of tracheal
aspirates.

α-amylase and pepsin were
significantly correlated (R2
=0.305, p=0.001).

Filloux B, Bedel A,
Nseir S. Tracheal
amylase dosage as
a marker for
microaspiration: a
pilot study.
Minerva
Anestesiol.
2013;79(9), 10031010.

Assess the
ability to use αamylase as a
diagnostic tool
in quantifying
microaspiration
of oral
secretions.

(n=26)
intubated
high-risk
patients
yielded 277
paired oral/
tracheal
specimens.
12 (n=12)
nonventilated
patients

Prospective
study

Twenty-six patients were
intubated for at least 48 hours
with a subglottic suction ETT,
were considered high risk of
microaspiration. Twelve nonventilated patients that required a
bronchoscopy made up the lowrisk control group. Tracheal (T)
amylase was compared between
the groups. In the intubated group,
a series of oral (O), subglottic (Sg)
and tracheal (T) suction samples

17

Tracheal amylase was lower
in the control group than the
intubated group (191 [10–
917]
Vs .6661 [2774–19,358]
IU/L, p <0.001). Amylase
gradually increased from
tracheal (6661 [2774-19,358]
IU/L), to subglottic (130,750
[55,257-157,717] IU/L), to
oral samples (307,606
[200,725-461,300] IU/L),

Weaknesses include the
sample size at a single
institution, markers for
microaspiration were not
measured during the
whole period of
mechanical ventilation,
and while the definition
of microaspiration as the
presence of pepsin at a
significant level is likely
correct, this only applies
to aspiration of gastric
contents. This could
have altered the accuracy
of the assessment. The
cut-off of 1688 IU/L
might have artificially
strengthened the results.
Amylase is a simple,
stable, and inexpensive
enzyme to measure, and
gives reproducible
results. Beyond the
crude quantitative
assessment of tracheal
amylase, the
tracheal/oral amylase
ratio may enable
quantification of
microaspiration.

Study

Purpose

Sample
Size

Study Design

that
required a
bronchosco
py yielded
12 paired
specimens
(the control
group).

Methodology and Instruments

Findings and Conclusions

were collected and T/O, T/Sg,
Sg/O amylase ratios were
determined.

resulting in a median 5.5%
T/O ratio.

This study indicated that T/O
amylase ratio could be used
towards quantifying
microaspiration of oral
secretions in mechanically
ventilated patients.

Comments/Limitations

Limitations include
contamination of the
tracheal secretions with
oral secretions during the
bronchoscopy, the use of
an open tracheal
suctioning system, and
the study’s limited
collection centers and
subject number.

Jaillette, E.,
Brunin, G., Girault,
C., Zerimech, F.,
Chiche, A., Behal,
H., Chiche, A., . . .
Nseir, S. (2017).
Impact of taperedcuff tracheal tube
on micro-aspiration
of gastric contents
in intubated
critically ill
patients: A
multicenter clusterrandomized crossover controlled
trial study protocol
for a randomized
controlled trial.
Intensive Care
Medicine, 43,
1562-1571.

The aim of this
study was to
determine the
influence of the
shape of
tracheal cuff on
abundant
microaspiration
of gastric
contents in
critically ill
patients.

A total of
326
patients
were
enrolled in
the ten
participatin
g ICUs
(162 in the
PVC
taperedcuff group
and 164 in
the
standardcuff group

Clustered
randomized
controlled
trial

In ten different French ICU’s
patients who were older than 18
that were intubated, had at least 48
hours of mechanical ventilation,
weren’t pregnant, could receive
enteral feedings, and screened
positive for 72 hours and over
intubation were eligible for the
study.

A total of 326 medical
patients were randomized in
the 10 participating ICUs.
Pepsin and salivary amylase
were quantitatively measured
in 2739 tracheal aspirates
coming from 303 patients.
Amylase levels >1685 IU/L
in >30% of tracheal aspirates
per patient were defined has
an abundant amount. No
tracheal secretions were
present in 23 patients. The
median number of tracheal
aspirates per patient in which
pepsin and salivary amylase
were measured was similar
in the two groups.

Tapered-cuff tracheal
tube was not superior to
standard-cuff tracheal
tube in reducing
microaspiration of
gastric contents. The
results suggested that
tapered-cuff tracheal
tube should not be used
to prevent
microaspiration or VAP
in ICU patients.

Nandapalan, V.,
McIlwain, J. C., &
Hamilton, J. A

The aim of this
study was to
evaluate

15 patients
ventilated
via a fresh

Descriptive
Study

Tracheobronchial secretions were
obtained from the patients on the
first, second, and third days.

Six out of the fifteen patients
showed very high levels of
amylase activity in their

All but one of the
patients developed a
form of a chest infection.
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Study

Purpose

Sample
Size

study of alphaamylase activity in
tracheobronchial
secretions of
seriously ill
patients with
tracheostomies.
Journal of
Laryngology and
Otology, 1995;
109, 640-643.

salivary
aspiration in
seriously ill
patients with
tracheostomies
and to see
whether there
was any
correlation with
subsequent
development of
chest infection.
The presence of
amylase in
tracheobronchia
l secretion was
used as an
indicator of
tracheobronchia
l contamination
by saliva.

tracheosto
my and all
had Shiley
tracheosto
my tubes.
Patients
had no
clinical or
radiologica
l evidence
of lung
disorder at
the time of
the study.

Study Design

Methodology and Instruments

Findings and Conclusions

Comments/Limitations

Samples from the trach tube were
collected via a sputum trap and a
sample of saliva was gathered
from each patient routinely. The
specimens were sent to the lab to
assess for alpha-amylase.

tracheobronchial secretions
and these levels increased
from Day 1 to Day 3.

Of the patients studied;
six were able to be
confirmed infection from
a salivary aspiration.

Alpha-amylase activity in the
samples was analyzed by the
blocked substrate maltoheptaose
method at 37°C. The presence of
amylase in tracheobronchial
secretion was used as an indicator
of tracheobronchial contamination
by saliva above and below the
cuff. Chest xray changes, bronch
findings, and partial pressure
changes across alveolar
membranes were looked at.

Bacteriological culture of the
sputum during the time of
chest infection revealed that
of the eight patients who had
anaerobic organisms, five
had clear evidence of
aspiration. Three patients
grew aerobic organisms and
in three patients there was
some growth of a mixed
flora in the sputum but there
was no significant
pathological count.

The control was the alphaamylase in tracheobronchial
secretions of patients who had
normal lungs.
Sole, M.L.,
Conrad, J.,
Bennett, M.,
Middleton, A.,
Hay, K., Ashworth,
S., Devendra, I.M
Pepsin and
Amylase in oral
and tracheal
secretions: A pilot
study. American

To assess the
presence of
pepsin and
amylase in
paired oraltracheal
secretions of
adult patients
being treated
with

10 men and
3 women
with a
median age
of 56 years.
Majority
were
intubated
with a
subglottic
suction

Descriptive
Design Study

In this descriptive study, samples
of oral and tracheal secretions
were obtained from adult patients
at baseline and again within 4
hours when a need for
endotracheal suctioning was
assessed. Assays of pepsin and
amylase were processed in a
specialty diagnostic laboratory.
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Pepsin was present in oral
secretions of 9 patients
(69%), and in tracheal
specimens of 7 patients
(54%) at one or both
sampling times. Amylase
was detected in all patients’
oral secretions and in
tracheal secretions of 5
patients (38%) at one or both
sampling times. Pepsin was

Patients 1,2,3,4 and 5
had an increase in the
percentage ratio of
tracheobronchial
amylase to salivary
amylase. As well as, in
the absolute amylase
levels in the
tracheobronchial on Day
3. It is likely that
contamination of the
trachea is beyond the
cuff which could have
led to chest infections
amongst the patients.
Since the chest
infections are not always
associated with salivary
aspiration, the reason for
severe chest infection in
patients 7 and 13.
Micro-aspiration of oral
and gastric secretions
does occur frequently.

Study

Purpose

Sample
Size

Journal of Critical
Care, 23(4), 334–
338.

mechanical
ventilation.

endotrache
al tube
(69%); and
85% were
receiving
enteral
feedings
with the
majority
(67%)
gastric.

Samanta S, Poddar
B, Azim A, Singh
RK, Gurjar M,
Baronia AK.
Significance of
mini
bronchoalveolar
lavage fluid
amylase level in
ventilatorassociated
pneumonia.
Critical Care Med.
2018;46(1),71-78.

Assess if αamylase in
mini-BAL
specimens can
be indicative of
VAP in
intubated
patients with
high clinical
suspicion.

151
patients.

Study Design

Methodology and Instruments

Findings and Conclusions

Comments/Limitations

more commonly detected
than was amylase.

Prospective
singlecentered
observational
study.

Mini-BAL samples were collected
within 72 hours of endotracheal
intubation.
Samples were sent for α-amylase
level assay and quantitative
culture. VAP was confirmed with
mini-BAL microbial cultures of
greater than or equal to 10
cfu/mL, and patients were divided
into VAP and no VAP groups.
Pre- and post-intubation risk
factors for aspiration were
assessed.

Presence of VAP 64.9%
(n=98) of the 151 patients.
Median mini-BAL amylase
levels in VAP group were
287 IU/L and no VAP group
94 IU/L, (p < 0.001).
Median amylase level in
patients with 0, 1, 2, and 3
pre-intubation risk factors
respectively were 65 U/L,
200 IU/L, 867 IU/L, and
3453 U/L (p < 0.001).
Median amylase in patients
with 1 and 2 post intubation
risk factors were 472 IU/L
and 731 IU/L (p <0.001).

Limitations include the
lack of a gold standard
of diagnosis for
aspiration, a single
measurement of amylase
may not reflect the
actual clinical situation,
oral care and
endotracheal suctioning
may increase the risk of
aspiration, and the small
sample size needs to be
expanded to further
validate α-amylase as a
diagnostic tool.

Patients with VAP have
higher mini-BAL amylase
levels than non-VAP and
amylase levels increase with
the number of risk factors.
Qu G-P, Fang X-Q,
Xu Y-P. Predictive

Investigates
correlations of

147 elderly
ventilated

Retrospective
analysis of

Tracheal aspirates were collected
from elderly patients within two
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α-amylase level increased
with the amount of risk

α-amylase can serve as a
predictive tool for VAP.

Study

Purpose

Sample
Size

Study Design

Methodology and Instruments

Findings and Conclusions

Comments/Limitations

value of a-amylase
in tracheal
aspirates for
ventilatorassociated
pneumonia in
elderly patients.
Clin Respir J.
2018;12(4),16851692.

α-amylase in
tracheal
aspirates and
aspiration risks
with incidence
of ventilatorassociated
pneumonia
(VAP) in
elderly patients
undergoing
mechanical
ventilation.

patients
grouped
based on
the
presence of
VAP.

prospectively
collected
data.

weeks of tracheal intubation and
α-amylase was assessed.

factors for aspiration in place
prior to intubation.

Patients were placed in groups
based on VAP diagnosis.
Relationships between α-amylase
and aspiration risks were assessed
before intubation and VAP.

α-amylase level was
significantly higher in the
VAP group than in the nonVAP group.

Regardless of the
occurrence of VAP,
tracheal aspirate α‐
amylase level increased
with the increase in the
number of risk factors
for aspiration before
intubation; tracheal
aspirate α‐amylase level
was significantly higher
in VAP patients than in
non‐VAP patients,
wherein the higher the
number of times the
tracheal aspirate α‐
amylase value exceeded
4681.5 IU/L, the higher
the possibility of VAP
was.

Examines
clinical value of
α-amylase for
predicting VAP.

Logistic multivariate
analysis revealed the
following risk factors for
VAP: having >=3 risk
factors before intubation,
Glasgow scores of <8, the
absence of continuous
aspiration of subglottic
secretion, and a tracheal
aspirate α-amylase level of
>4,681.5 IU/L.

α-amylase could work as
a predictor of aspiration
and VAP.
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Study

Purpose

Sample
Size

Study Design

Methodology and Instruments

Findings and Conclusions

Comments/Limitations

Weiss, C. H.,
Moazed, F., &
Wunderink, R. G.
Bronchoalveolar
lavage fluid
amylase is

To determine
whether
amylase only
produced in the
salivary glands
and
gastrointestinal
tract found in
bronchoalveolar
lavage fluid is
associated with
an increased
risk of
aspiration.

591
patients in
an ICU

Retrospective
Study

Nonbronchoscopic or
bronchoscopic specimens were
collected within 72 hours of
endotracheal intubation.
Collection of the data was done
blinded and aspiration risk factors
were included. Significance was
determined by the Wilcoxon ranksum tests. Data was presented as
interquartile range.

Data from 93 patients of the
591 were analyzed. Median
BAL amylase was higher in
patients with at least one
aspiration risk factor
compared to zero (264
units/L. vs 70 IU/L, <0.001
p). Median amylase
increased as the number of
aspiration risk factors
increased. Median amylase
was higher in patients with a
positive BALF Gram stain,
and higher in patients with a
positive culture for bacteria,
normal flora, or yeast
compared to a negative
culture (25.15 IU/L[94 IU/L832 IU/L] vs.63 IU/L [22
IU/L], p<0.001). There was
no difference in BAL
amylase patients with a
new/progressive pulmonary
infiltrate vs.
unchanged/improving
infiltrate.

Aspiration of
oropharyngeal or gastric
contents into the
respiratory tract needs
additional study. The
diagnosis for aspiration
was rather difficult due
to the criteria of
aspiration. Therefore, it
was difficult to have
statistical evidence from
one etiology of
aspiration.

elevated in patients
with a high risk of
aspiration.
American Journal
of Respiratory and
Critical Care
Medicine, 2011;
183, A3915.

High levels of amylase
in bronchoalveolar
lavage fluid (BALF)
fluids are associated with
both increased risk of
aspiration and evidence
of microbial infection.
Amylase may be useful
tool for diagnosis
aspiration.

BAL, bronchoalveolar lavage; EBP, Evidence Based Practice; ES, Expectorated sputum ICU, intensive care unit; VAP, ventilator associated pneumonia
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